Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
- Conditions
- Fibrolamellar CarcinomaFibrolamellar Liver Cancer
- Interventions
- Drug: letrozole plus leuprolideDrug: combination of everolimus, letrozole and leuprolideDrug: everolimus
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT01642186
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸John Hopkins Medical Center, Baltimore, Maryland, United States
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- First Posted Date
- 2012-07-12
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 86
- Registration Number
- NCT01639508
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
- Conditions
- Chinese Immigrants With Breast Cancer
- Interventions
- Behavioral: in-person support groupBehavioral: virtual support group
- First Posted Date
- 2012-07-04
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT01632956
- Locations
- 🇺🇸
Queens Cancer Center of Queens Hospital, Jamaica, New York, United States
Improving End of Life Care in Head and Neck Cancer
- Conditions
- Upper Aerodigestive TractThe Families or Next of Kin of Patients Treated at MSKCC for Non-cutaneous Squamous Cell Carcinomas of the
- Interventions
- Behavioral: The The Family Assessment of Treatment at the End of life (FATE ) survey
- First Posted Date
- 2012-07-04
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT01632969
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT01622660
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
- Conditions
- Metastatic Breast Cancer to the Brain
- Interventions
- Device: 18F-FLT-PET Imaging
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01621906
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Webcore telephone survey system
- First Posted Date
- 2012-06-12
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT01617174
Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer
- Conditions
- Cervical Cancer
- Interventions
- Other: DCE-MRI and 18F-FMISO PET
- First Posted Date
- 2012-06-07
- Last Posted Date
- 2014-03-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT01613521
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
- First Posted Date
- 2012-05-28
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 210
- Registration Number
- NCT01606787
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
- Conditions
- Brain Cancer
- Interventions
- Diagnostic Test: MRI perfusion and PET/CT scans
- First Posted Date
- 2012-05-23
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 147
- Registration Number
- NCT01604512
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States